Biocon Ltd. | Balance Sheet

Fiscal year is April-March. All values INR Millions.
2014
2015
2016
2017
2018
Cash & Short Term Investments
15,048
11,678
24,644
22,152
20,337
Total Accounts Receivable
7,256
8,615
8,989
10,383
12,554
Inventories
3,766
4,527
5,424
6,353
7,225
Other Current Assets
318
806
823
1,930
1,370
Total Current Assets
26,388
25,626
39,880
40,818
41,486
Net Property, Plant & Equipment
26,201
31,334
38,260
41,372
44,881
Total Investments and Advances
645
-
882
2,980
1,747
Long-Term Note Receivable
754
685
26
-
-
Intangible Assets
1,442
2,320
2,470
3,787
5,937
Other Assets
2,076
3,789
2,348
3,010
3,912
Total Assets
57,596
63,877
85,267
94,858
100,922
ST Debt & Current Portion LT Debt
2,576
3,476
4,308
2,767
4,742
Accounts Payable
3,472
4,395
6,098
7,397
10,244
Income Tax Payable
472
298
965
964
891
Other Current Liabilities
7,276
7,378
5,286
5,655
5,536
Total Current Liabilities
13,796
15,547
16,657
16,783
21,413
Long-Term Debt
6,062
7,696
20,724
21,082
17,898
Provision for Risks & Charges
78
150
299
360
493
Deferred Taxes
450
417
715
1,975
1,934
Other Liabilities
6,030
5,516
3,905
3,579
3,608
Total Liabilities
26,506
29,449
42,271
42,720
44,437
Common Equity (Total)
30,267
32,706
40,338
48,377
51,808
Total Shareholders' Equity
30,267
32,706
40,338
48,377
51,808
Total Equity
31,090
34,428
42,996
52,138
56,485
Liabilities & Shareholders' Equity
57,596
63,877
85,267
94,858
100,922
Accumulated Minority Interest
823
1,722
2,658
3,761
4,677

About Biocon

View Profile
Address
20th KM, Hosur Road
Bangalore Karnataka 560100
India
Employees -
Website http://www.biocon.com
Updated 09/14/2018
Biocon Ltd. is a holding company, which engages in the manufacture, research, and development of therapeutic drugs. It operates through the following segments: Small Molecules, Biologics, Branded Formulations, and Research Services. The Small Molecules segment manufactures spanning statins, immunosuppressants, antifungals, anti-obesity, anti-diabetics, ophthalmologicals, oncologicals, and urologicals etc.